Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

ISBIOMECH

Financiado

Intelligent Device and Computational Software to Control Mechanical Stress and D...

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing In nature, all biological material from the cell to the tissue level is subjected to continuous mechanical stress and strain. These mechanical cues play an essential role on several biological processes and can determine the fate... ver más

30/11/2024

UC3M

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

UNIVERSIDAD CARLOS III DE MADRID No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1332

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-17

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2022-POC2: ERC PROOF OF CONCEPT GRANTS2

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

UC3M

150.00K€ | Lider

Proyectos interesantes

DPI2010-20746-C03-01 DESARROLLO DE UNA HERRAMIENTA COMPUTACIONAL DE INTERACCION F... 159K€ Cerrado

JCI-2008-2940 Biomateriales, Biomecánica e Ingeniería de Tejidos 101K€ Cerrado

ForceDelivery Mechanosensitive proteins as a pathway to mechano-targeted d... 184K€ Cerrado

JCI-2010-07305 Biomateriales, Biomecanica e Ingenieria de Tejidos 101K€ Cerrado

DPI2013-46641-R DESARROLLO DE MODELOS MICROESTRUCTURALES DE TEJIDO OSEO Y AP... 90K€ Cerrado

PID2020-113790RB-I00 EL PAPEL DE LA MECANICA EN LA OSTEOPOROSIS: UN MODELO DE DIS... 197K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 19 meses Fecha Inicio: 2023-04-17
Fecha Fin: 2024-11-30

Líder del proyecto

UNIVERSIDAD CARLOS III DE MADRID

Total investigadores 1332

Presupuesto del proyecto 150K€

Descripción del proyecto In nature, all biological material from the cell to the tissue level is subjected to continuous mechanical stress and strain. These mechanical cues play an essential role on several biological processes and can determine the fate of a healing or a cancerous process, among many others. Therefore, research activities focusing on studying the deterministic nature of these processes need a robust test platform that allows for reproducing these mechanically-varying environments. Such a system would significantly contribute to improving in-vitro testing of therapies and drug discovery, incorporating the essential influence of mechanics in pharmaceutical and biotechnological companies. However, the current approaches are restricted to basic science methods with important limitations. This lack of a suitable system hinders the translation of basic science in mechanobiology to its application in the industrial-technological field. ISBIOMECH proposes a novel intelligent system to control the mechanical environment of cellular/tissue materials, to be commercially exploited as laboratory equipment for mechanobiology research and pathological treatment testing. The novel device and associated software will provide the first commercially available system to allow for robust and reproducible in-vitro testing of mechanically-influenced biological processes. More concretely, the system will use magneto-responsive substrates allowing for non-invasive, multidimensional and real-time control of complex deformation modes on cellular/tissue materials. This technology will be implemented and validated by demonstration activities at stakeholders’ labs to address timely mechanobiological studies in epithelial wound healing, neurological disorders and cardiac pathology. The proposed system has the potential to open the experimental path to improve current treatments in, e.g., cancer pathologies, pathological skin scarring or fibrotic heart remodelling during myocardial infarction.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores